Abstract. Secl2p is an integral membrane protein required in vivo and in vitro for the formation of transport vesicles generated from the ER. Vesicle budding and protein transport from ER membranes containing normal levels of Secl2p is inhibited in vitro by addition of microsomes isolated from a Sec12p overproducing strain . Inhibition is attributable to titration of a limiting cytosolic protein . This limitation is G NETic analysis has identified four yeast genes that are required for the formation of transport vesicles derived from the ER: SEC12 SEC13 SEC16 and SEC23 (Kaiser and Schekman, 1990) . In vitro reconstitution of ER-Golgi transport vesicle formation also showed a requirement for Secl2p and Sec23p (Rexach and Schekman, 1991) . Cell fractionation and DNA sequence analysis have shown that Secl2p is an integral membrane protein, and Sec23p, Secl6p, and Secl3p are either cytosolic or peripheral membrane proteins (Nakano et al., 1988 ; Hicke and Schekman, 1989; Kaiser, C., and N. Pryer, unpublished data) . Interactions observed among the genes encoding these proteins suggest that they could act in concert or form a multisubunit complex possibly associating with the ER membrane via Secl2p (Kaiser and Schekman, 1990) .
quired in vivo and in vitro for the formation of transport vesicles generated from the ER. Vesicle budding and protein transport from ER membranes containing normal levels of Secl2p is inhibited in vitro by addition of microsomes isolated from a Sec12p overproducing strain . Inhibition is attributable to titration of a limiting cytosolic protein . This limitation is G NETic analysis has identified four yeast genes that are required for the formation of transport vesicles derived from the ER: SEC12 SEC13 SEC16 and SEC23 (Kaiser and Schekman, 1990) . In vitro reconstitution of ER-Golgi transport vesicle formation also showed a requirement for Secl2p and Sec23p (Rexach and Schekman, 1991) . Cell fractionation and DNA sequence analysis have shown that Secl2p is an integral membrane protein, and Sec23p, Secl6p, and Secl3p are either cytosolic or peripheral membrane proteins (Nakano et al., 1988 ; Hicke and Schekman, 1989; Kaiser, C., and N. Pryer, unpublished data) . Interactions observed among the genes encoding these proteins suggest that they could act in concert or form a multisubunit complex possibly associating with the ER membrane via Secl2p (Kaiser and Schekman, 1990) .
Secl2p is a type II membrane glycoprotein with a 40 kD NH2-terminal cytosolic domain that is essential for transport, and a COON-terminal lumenal domain that is dispensable (Nakano et al., 1988 ; d'Enfert, C., C. Barlowe, S. Nishikawa, A. Nakano, and R. Schekman, manuscript submitted for publication) . The thermosensitive lethality associated with a mutation in the NH2-terminal domain of Secl2p is suppressed by overproduction of Sarlp, a 21-kD GTP-binding protein (Nakano and Muramatsu, 1989) . Sarlp is itself required for protein transport from the ER (Nakano and Muramatsu, 1989) . Cell fractionation experiments show Sarlp both in the cytosol and in tight association with a membrane fraction, however overproduction increases the fraction of Sarlp soluble in the cytosol . Membrane association of Sarlp is enhanced in vivo overcome by addition of a highly enriched fraction of soluble Sarlp, a small GTP-binding protein, shown previously to be essential for protein transport from the ER and whose gene has been shown to interact genetically with sec12 . Furthermore, Sarlp binding to isolated membranes is enhanced at elevated levels of Secl2p . Sarlp-Secl2p interaction may regulate the initiation of vesicle budding from the ER.
by overproduction of Secl2p (d'Enfert, C., C. Barlowe, S. Nishikawa, A. Nakano, and R. Schekman, manuscript submitted for publication) . These results suggest a structural and functional interaction of Sarlp and Secl2p.
In the course of identifying cytosolic factors that stimulate protein transport from the ER in vitro, we observed that addition of a membrane fraction with elevated levels of Secl2p was inhibitory, and that a limiting cytosolic factor restored transport when provided in an enriched form . This report describes the identification of this limiting factor as Sarlp. Extensive purification of a functional, apparently monomeric soluble form of Sarlp is achieved.
Materials and Methods
Strains, Plasmids, Materials, and General Methods
663
University of California,
The yeast strains used in this study were RSY607 (leu2-3,112 ura3-52 pep4 :: URA3 MATE) and YPH500 (ura3-52 lys2-801 ade2-101 trpl-063 his3-A200 leu2-Al MAT4; Sikorski and Hieter, 1989) . Plasmids pANYI-9 (2P URA3 SEC12), pCEY5 (2w URA3 GALI-SEC12), pANY2-7 (2p URA3 SARI), pANY2-18 (CEN4-ARS1 TRP1 GALL-SARI), and pSEY8 have been previously described (Nakano et al ., 1988 ; d'Enfert, C., C . Barlowe, S . Nishikawa, A . Nakano, and R . Schekman, manuscript submitted for publication ; Nakano and Muramatsu, 1989 ; Emr et al ., 1986) . pCGS109 (2P URA3 GALL-GAL10) is a gift of D . Moir (Collaborative Research, Lexington, MA) . pSEC1313 (2p URA3 SEC13) and pSEC-1614 (2F+ URA3 SEC16) were kindly provided by C . Kaiser (Division of Biochemistry and Molecular Biology, and Howard Hughes Medical Institute, University of California, Berkeley, CA) .
Yeast cells were grown in YP (2 % Bacto-peptone 1% Yeast extract broth both from Difco Laboratories Inc., Detroit, MI) containing 2% glucose or in MV (0.67 % yeast nitrogen base without amino acid ; Difco Laboratories Inc .) containing 2% glucose and supplemented with the appropriate amino acids and/or 0.5 % vitamin assay Casamino acids (Difco Laboratories Inc .) .
For induction of GALI-regulated genes, cells were first grown in MV containing 2 % lactate, pH 5.5, 0.1 % glucose, and then induced by transfer in either YP 2 % galactose for 20 h or MV 2 % lactate, pH 5 .5, 2 % galactose for 5 h .
Anti-Sec12p, anti-Sarlp, anti-Sec23p, anti-Kar2p, and antia,1-6-man-nose antibodies have been described (Nakano et al ., 1988 ; Nishikawa and Nakano, 1991 ; Hicke and Schekman, 1989 ; Rose et al ., 1989; Baker et al ., 1988) . Anti-Seel3p, anti Yptlp, and anti-phosphoglycerokinase were kindly provided by C . Kaiser, D. Baker, and J . Thorner, respectively (Division of Biochemistry and Molecular Biology, and Howard Hughes Medical Institute, University of California, Berkeley, CA) . Transfer of proteins from SDS-PAGE gels to nitrocellulose filters (Schleicher & Schuell, Inc ., Keene, NH) was performed as described (Towbin et al . , 1979) . Filters were blocked and all incubations were conducted in 20 mM Tris-Cl, pH 7.4, 150 mM NaCl, 0.1 % NP-40 with or without 2 % non-fat dry milk . Detection of filterbound antibodies with horseradish peroxidase-conjugated goat anti-rabbit IgG and with ECL immunoblotting reagents were performed accoi .iing to the supplier's instructions (Amersham Corp., Arlington Heights, IL) . Protein concentrations were determined by the procedure of Lowry et al . (1951) in the presence of 1% sodium dodecyl sulfate or with the Bio-Rad protein assay (Bio-Rad Laboratories, Richmond, CA) using BSA as a standard .
Preparation ofSubcellular Fractions for In Intro Assays
Subcellular fractions were prepared from wild-type cells grown in YP 2% glucose or from transformed cells grown in YP 2% galactose (cytosol) or MV 2% lactate, 2% galactose (cytosol, microsome, and high speed pellet fractions) . Cytosol was prepared from bead-lysed cells as described (Baker et al ., 1988) and concentrated (12-15 mg protein/ml) by centrifugation in Centriprep-10 unit (Amicon Corp., Danvers, MA) . Preparations of microsomes and high speed pellet (HSP) fractions from osmotically-lysed cells were carried out according to Baker et al . (1990) except that glucose was replaced by galactose during the formation of spheroplasts when fractions were prepared from cells grown in the presence of galactose . Alternatively, the high speed pellet fraction was obtained after a 100,000-g centrifugation of a 12,000-g supernatant from a bead-lysed cell extract (Baker et al ., 1988) . This HSP fraction (20 mg protein/ml) had a lower specific transport activity but stimulated ER-Golgi transport as efficiently as an HSP fraction derived from osmotically lysed cells .
In Intro Assays and Microsome-dependent Inhibition 'Itvo-stage in vitro transport reactions were carried out as described (Baker et al ., 1990 ) using 35S-labeled prepro-a-factor (Baker et al ., 1988) , microsomes (10 wg protein), cytosol (110-150 pg protein) ; and HSP fractions (20-40 pg protein) in a total reaction volume of 50 pl. Transport conditions were adjusted so that activity was linearly dependent upon addition of cytosol and HSP fractions and are noted in the figure legends. Reactions were incubated for 2 h at 20°C and terminated by addition of 50A12 % SDS followed by heating at 95°C for 5 min . The total amount of glycosylated pro-a-factor was quantified by precipitation with concanavalin A-Sepharose ; Golgi-modified forms of pro-a-factor were quantified by precipitation with an antiserum specific for (al-6)-linked mannose and protein A-Sepharose as described (Baker et al ., 1988) . In these conditions, transport efficiency (ratio of Golgi-modified/total glycosylated pro-a-factor) was typically 25% and was linearly dependent upon addition of cytosol and HSP fractions .
'Ihvo-stage in vitro budding reactions were carried out using microsomes (2 .5 Rg protein) and cytosol (470 jig protein) in a total reaction volume of 50 Al (Wuestehube, L ., and R . S . Schekman, manuscript in preparation) . Reactions were incubated for 30 min at 20°C and terminated by centrifugation at 27,000 g for 10 min . The total reaction mixture and supernatant fraction were treated with trypsin (0.3 mg/ml, 60 min, 4°C) followed by trypsin inhibitor (1 .2 mg/ml, 10 min, 4°C) . Samples were heated at 95°C for 5 min in the presence of 1 % SDS and the amount of glycosylated pro-a-factor was quantified by precipitation with concanavalin A-Sepharose as described (Baker et al ., 1988) . Efficiency of vesicle release (ratio of supernatant/total glycosylated pro-a-factor) typically was 24% .
To test the inhibitory effects of competitor membranes, microsomes (0.5-5 mg protein/ml) were treated first with trypsin (0.2 mg/ml, 30 min, 4°C) and then with trypsin inhibitor (0 .5 mg/ml, 10 min, 4°C) . Trypsin treatment did not affect the integrity of the ER membranes since the luminal protein Kar22p remained enclosed within the sedimentable material (not shown) . Various amounts of trypsin-treated membranes were added to
The Journal of Cell Biology, Volume 114, 1991 cytosol and HSP fractions and the concentrations of trypsin and trypsin inhibitor were adjusted accordingly. Alternatively, trypsin-treated membranes were washed by centrifugation (27,000 g, 10 min) in reaction buffer to remove soluble trypsin and trypsin inhibitor. After a 10-min incubation on ice, microsomes containing translocated 35 S-pro-a-factor were added and the second stage of the reaction was initiated . An 80% inhibition was reproducibly obtained with 4-5 jig of Sec12p-enriched membranes .
To test the rescue activity of various fractions, cytosol and HSP fractions were mixed with the appropriate amount of trypsin-treated Sec12p-enriched microsomes such that -80% inhibition was obtained in the absence of any additional component . This mixture was kept on ice for 10 min, distributed into tubes containing the fractions to be tested, and incubated an additional 10 min on ice. Microsomes containing translocated 35S-pro-a-factor then were added and the second stage of the reaction was conducted .
Gel Filtration of Yeast Cytosols
Cytosol was prepared from YPH500(pANY2-18) as described above . A 400-Al aliquot of cytosol (5.9 mg) in reaction buffer containing 1 mM DTT, 0.5 mM PMSF, 1 mM ATP, and 0.1 mM GTP was loaded onto a 20 ml (1 .0 x 25 cm) Sephacryl S-100 HR (Pharmacia Inc ., Piscataway, NJ) gel filtration column equilibrated in reaction buffer. The column was eluted in the same buffer at^+12 ml/h . Fractions (400 Al) were collected and total protein and rescue activity in each fraction was determined . Fractions were resolved by SDS-PAGE, visualized by silver stain (Morrisey, 1981) , and examined for Sarlp content by immunoblot. As a control, cytosols not enriched in Sarlp were prepared from YPH500(pANY2-18) and YPH500-(pCGS109), adjusted to a protein concentration of 9.5 mg/ml, and fractionated using the same S-100 HR gel filtration column .
Sarlp Membrane Binding Assay
Trypsin-treated microsomes (20 log) were prepared as described above and mixed with various fractions containing soluble Sarlp in a final reaction buffer volume of 40 AI . BSA (1 mg/ml) was included when partially purified Sarlp was used in order to avoid proteolysis . After a 5-min incubation at 4°C, the membrane fraction (Fig . 7 , MSP) was separated from the soluble fraction ( Fig . 7 , MSS) by a 25,000-g centrifugation for 10 min in a TLA 100 rotor (Beckman Instruments, Inc ., Palo Alto, CA) . The supernatant fraction was then recovered and diluted with SDS-PAGE loading buffer (5x) . The pellet was washed twice with reaction buffer and resuspended in SDS-PAGE loading buffer (lx) . Both fractions were analyzed by SDS-PAGE and inununoblotting using anti-Sarlp and anti-Sec12p antibodies as well as several control antibodies raised against three peripheral membrane Sec proteins (Sec23p, Yptlp, and Sec13p) and a cytosolic protein (phosphoglycerokinase, PGK) . Displacement of soluble Sarlp into the Sarlpdepleted microsomal fraction was then assayed by comparing the Sarlp content of each fraction . Sec12p-dependent membrane binding was observed only for Sarlp and no significant membrane binding was observed with Sec23p, Yptlp, Sec13p, and PGK .
Results

Secl2p-enriched Membranes Inhibit Transport
Protein transport from the ER to the Golgi apparatus has been reconstituted with yeast membranes and cytosol (Baker et al., 1988 (Baker et al., , 1990 Ruohola et al., 1988) . In the first stage of transport, [35 S]methionine-labeled a-factor precursor is translocated into a crude ER membrane fraction to form core-glycosylated precursor. Transport to the Golgi complex is achieved in a second stage which measures the coupled addition of outer chain carbohydrate to the core-glycosylated precursor. In the assay developed by Baker et al. (1990) , transport is stimulated by a cytosol fraction (100,000-g supernatant), a particulate fraction (HSP; 100,000-g pellet), and ATP The particulate fraction appears to provide an enriched source of factors that are present in limited supply in thecytosol, ratherthan an essential membrane compartment . Addition of a salt wash soluble fraction, obtained by extraction ofpermeabilized spheroplasts, replaced the requirement for HSPmaterial (Baker, D. and L. Wuestehube, unpublished results) .
To identify cytosolic factors that interact with Secl2p, we designed an assay in which these components become limiting through titration by excess Secl2p . This was achieved by mixing wild-type ER membranes containing 35 S-coreglycosylated pro-a-factor with nonradioactive membranes isolated from cells transformed with a multicopy vector containing the SEC12 gene . An outline of this approach is depicted in Fig . 1 . If the inhibitory membranes consume a specific limiting component, inhibition should be overcome Increasing amounts of trypsin-treated microsomes derived from a control strain (YPH500(pCGS109) ; YEp : :GAL) or a strain overproducing Secl2p (YPH500(pCEY5) ; YEp : :Gal-SEC12), both of which were grown in galactosecontaining medium, were preincubated with the cytosol and the HSP fractions for 10 min at 0°C before mixing with the membranes that contained pro-a-factor . The efficiency of transport for each reaction was compared to the maximum transport efficiency obtained when competitor membranes were omitted (25%) . Membranes were isolated from two strains varying only in their content of Secl2p . Wild-type (YPH500/pCGS109 ; YEp : :GAL) and a Secl2p-overproducing strain (YPH500/ pCEY5 ; YEp: :GAL-SEC12) were grown on galactose to induce maximal synthesis of Secl2p in the latter. Membranes were isolated and treated with trypsin under conditions where Secl2p remains intact, but ER-Golgi transport activity is inactivated (Nakano et al., 1988 ; d'Enfert, C., unpublished data) . Membranes from the transformant contained at least 60-fold more Secl2p than preparations from wild-type cells. Equivalent amounts of membrane protein from transformed and untransformed cells were mixed with cytosol and HSP fractions for 10 min at 0°C, and aliquots then added to a stage II incubation containing wild-type ER membranes loaded with [ 35 S]a-factor precursor. Transport inhibition related to the amount of Secl2p in the overproducer membrane fraction was observed (Fig . 2) . Competitor membranes isolated from cells transformed with a multicopy plasmid containing SEC12 under control of its own promoter (six-to eightfold less Secl2p than the GAL-regulated SEC12) were threefold more potent than control membranes in inhibiting transport (not shown) . Inhibition was proportional to but not linearly related to the Secl2p level . Not all of the Secl2p may be in a form capable of competing for a transport-limiting component .
Sarlp Is Limiting in the Inhibited Reaction
The model presented in Fig . 1 implies that Secl2p titrates a limiting cytosolic component, however, Secl2p could equally well limit a factor present in the membrane or HSP fraction . Trypsin treatment of the Secl2p-rich membrane should reduce the contribution of a peripheral membrane protein that could partition between the cytosol and membrane fraction. Indeed, trypsin treatment enhanced (1 .5-fold) the inhibitory potency of the competitor membrane fraction 665 Figure 1 . Inhibition of ER-Golgi transport by Secl2p-enriched membranes. In vitroreconstituted ER-Golgi transport monitors the transfer of core-glycosyaated 35S-labeled pro-a-factor (dotted circle) from the endoplasmic reticulum to the Golgi apparatus where it acquires outer-chain glycosylation (solid circle) . Interaction between Secl2p (membrane protein) and an unknown cytoplasmic component (solid triangle) is thought to be necessary for the production of a transport vesicle . Addition of Secl2p-enriched membranes to a standard transport reaction should result in a titration of this cytoplasmic component by these membranes and thus in an inhibition of transport . Figure 3 . Cytosol-dependent reversal of Sec12p-mediated inhibition. Cytosols prepared from RSY607 (WT) grown in YP 2% glucose and from YPH500(pSEY8) (YEp), YPH500(pANY2-7) (YEp: :SARI ), and YPH500(pANY2-18) (YCp : :GAL-SARI) grown in MV 2 % lactate 2 % galactose were compared for their Sarlp content and their effect on the Sec12p-dependent transport inhibition . (A) 25 ug of each cytosol was resolved by SDS-PAGE and immunoblotted with anti-Sarlp antibodies . (B) Standard transport reactions were carried out with wild-type membranes containing translocated pro-a-factor, 150 tLg wild-type cytosol, 40 lAg wildtype HSP prepared from bead-lysed cells, 5 jig trypsin-treated Sec12p-enriched microsomes, and increasing amounts of cytosol from each strain . The efficiency of transport for each reaction was compared to the maximum transport efficiency obtained when Sec12p-rich microsomes and additional cytosol were omitted (23%) . Addition of Secl2p-rich microsomes alone resulted in a 81% inhibition of transport .
(not shown) . Inhibition was partially overcome by addition of higher-than-normal levels of cytosol to incubations that contained the membrane mixture (Fig . 3 B) .
Given the known genetic interaction between sec12 and
The Journal of Cell Biology, Volume 114, 1991 SARI (Nakano and Muramatsu, 1989) , we examined the effect of cytosols prepared from strains transformed either with a 2p, multicopy vector carrying SARI under control of its own promoter, with a single-copy plasmid carrying SARI under control of the more active GALI-10 promoter, or with a control 2p. plasmid . The relative content of Sarlp in these cytosol fractions was compared by immunoblotting with a polyclonal antiserum (Fig. 3 A) . The 2t. SARI produced -20-fold more, and the CEN GAL: :SARI N45-fold more Sarlp than the untransformed and control transformed strains, as determined by densitometry of the SDS-PAGE immunoblot. Significantly greater rescue of transport was observed with cytosols that contained more Sarlp (Fig . 3 B) . Although the antidote effect was proportional but not linearly related to the level of Sarlp overproduction, other factors may become limiting or not all of the Sarlp may be functional . Other genes (SEC13, SEC16) have been associated with SEC12 by genetic analysis (Kaiser and Schekman, 1990) . Cytosol fractions prepared from cells transformed with multicopy vectors carrying these genes were no more potent than control cytosol in ameliorating inhibition by Sec12p-rich membranes, although they contained increased amounts of these SEC proteins (not shown) . Thus the inhibition by excess Sec12p is overcome by Sarlp or by some factor that is coordinately induced by overproduction of Sarlp.
To examine the specificity of rescue by Sarlp, cytosol from the GAL :: SARI transformant was fractionated by gel filtration on Sephacryl S-100HR . Sarlp filtered in the included volume with a peak of immunoreactive material in fractions 30-34 (Fig . 4 A) . Rescue assays were performed by mixing trypsin-treated Secl2p-rich membranes with a normal dose of the cytosol and HSP fractions and aliquots of the Sephacryl column fractions . After 10 min at 0°C the mixture was added to wild-type membranes containing pro-a-factor followed by incubation in a stage II transport reaction . Rescue activity fractionated coincidentally with Sarlp and was recovered in 18 % yield with respect to the starting cytosol fraction . This level of recovery is consistent with the possibility that another cytosolic factor became limiting in the presence of competitor membranes . Although Sarlp is a 21-kD protein (Nakano and Muramatsu, 1989) , the polypeptide eluted from the Sephacryl column at the position expected of a 7 .5-kD protein . This may account for the striking separation of Sarlp (Fig . 4 B, closed circles) from the total protein (open circles) on this column. Indeed, SDS-PAGE of Sarlp peak fractions of the Sephacryl column showed the protein highly enriched in relation to other polypeptides (Fig. 5) . Sarlp overproduction was insufficient to detect a difference in SDS-PAGE comparison of cytosol fractions prepared from untransformed and transformed cells (not shown) . Parallel Sephacryl fractionation of cytosol from a control strain grown on galactose showed little rescue activity (not shown) and Sarlp was not detected in equivalent column fractions (Fig . 5 ) . Sarlp appears to be directly responsible for reversal of the inhibitory effect of excess Sec12p.
Sarlp Stimulates Vesicle Budding
Although Sarlp is required for protein transport from the ER (Nakano and Muramatsu, 1989) , a role in vesicle budding or fusion has not been distinguished . We used a vesicle budding assay that detects the release of transport vesicles from the ER to monitor the effect of Sec12p-rich membranes and rescue by Sarlp. In this assay, vesicle budding from an enriched ER fraction is monitored by the appearance of protease-protected core-glycosylated [35 S]pro-ct-factor in a slowly sedimenting compartment that is resolved from ER by differential centrifugation (Wuestehube, L., and R. S . Schekman, manuscript in preparation) . Vesicle release is cytosol-and energy-dependent and is retarded by GTPYS . Released vesicles are competent for transfer of core glycosylated pro-a-factor to a fresh supply of membranes.
Secl2p-rich membranes inhibited vesicle budding (Fig .  6 ) . Membranes isolated from the GAL-regulated SEC12 transformant decreased budding by 69%, whereas membranes isolated from an untransformed cell decreased budding by 4% . Budding inhibition was overcome by addition of cytosol from a Sarlp overproducing strain (restored to 75 % of normal), while the same amount of cytosol from an untransformed strain offered no rescue . Sephacryl S-100 d'Enfert et al . Secl2p and Sarlp Interact to Promote Vesicle Budding Figure 5 . Sarlp enrichment by gel filtration. Cytosols prepared from control (YPH-500(pCGS109) ; GAL) and Sarlp overproducing (YPH-500(pANY2-18) ; GAL-SARI) strains grown in YP 2 % galactose were fractionated on an S-100 HR gel filtration column. Fractions corresponding to the peak of rescue activity obtained with the Sarlp-enriched cytosol were resolved by SDS-PAGE followed by silver staining. The elution of Sarlp is indicated .
enriched fractions of Sarlp also were active as an antidote to inhibition of budding by Secl2p-rich membranes (not shown) . These results suggest that Sarlp interacts with Secl2p to facilitate the formation of transport vesicles from the ER .
Membrane Binding ofSarlp Is Stimulated by Secl2p
Secl2p may act to sequester Sarlp by recruitment to the membrane fraction or by inactivation of a form that remains cytosolic. Membranes containing normal or overproduced levels of Secl2p were used to examine recruitment of Sarlp from a crude cytosol orof Sarlp purified on Sephacryl S-100. Membrane fractions were treated with trypsin to remove endogenous Sarlp and mixed with crude or purified Sarlp fractions at 4°C. The content of Secl2p and the redistribution of Sarlp to membranes was evaluated by immunoblotting particulate (medium speed pellet [MSP] ) and soluble (medium speed supernatant [MSSJ) fractions resolved by SDS-PAGE (Fig . 7) . Secl2p was detected by immunoblot only in membranes derived from cells transformed with a multicopy vector containing SEC12 (Fig. 7, S, lanes 2, 4, 7 , and 10) ; Secl2p was only partially sensitive to trypsin cleavage (compare lane 2 with lanes 4, 7, and 10) . Untreated membranes from the SEC12 transformant contained more endogenous Sarlp than was found in untransformed control membranes (Fig . 7, compare lanes 1 and 2) . This species was quantitatively converted by trypsin to a Sarlp fragment (Fig . 7,  Sar1A ) that sedimented in the MSP fraction . Exogenous Sarlp became sedimentable only when mixed with a membrane fraction (Fig . 7 , compare lanes 5 and 8 with lanes 6 and 7 and 9 and 10), and the proportion of Sarlp recruited to membranes was enhanced by elevated levels of Secl2p (three-to fivefold, compare Fig . 7 , lanes 6 and 7, and lanes 9 and 10) . Recruitment to the membrane occurred at4°C and was independent of ATP or GTP (not shown) . Although membrane association of Sarlp occurred even with membranes that contained the normal low level of Secl2p, this could reflect some non-specific binding . Purified Sarlp binds to soybean phospholipid liposomes (Barlowe, C ., unpublished results) . Thus, at least part of the inhibitory effect of Secl2p-rich membranes on ER vesicle budding is due to membrane recruitment and sequestering of soluble Sarlp.
Sarlp is a small GTP-binding protein required for efficient protein transport from the endoplasmic reticulum to the Golgi apparatus (Nakano and Muramatsu, 1989 ; Nishikawa and Nakano, 1991) . The SARI gene was isolated as a multicopy suppressor of a thermosensitive mutation in the SEC12 gene which encodes a membrane glycoprotein involved in the formation of ER-to-Golgi transport vesicles (Nakano and Muramatsu, 1989 ; Kaiser and Schekman, 1990 ; Rexach and The Journal of Cell Biology, Volume 114, 1991 -18) ) . The efficiency of vesicle release for each reaction was compared to the maximum obtained when no additional fractions were added (24%) . The data shown is the average value of reac tions performed in triplicate and error bars represent + GAL-SARI the standard deviation . Schekman, 1991) . These results suggested that Sarlp could interact with the cytosolic domain of Secl2p to promote vesicle assembly . This assumption is now confirmed by our observation that Sarlp becomes limiting in a vesicle budding reaction when the level of Secl2p is elevated in a competitor membrane fraction . In addition, Secl2p-rich membranes bind Sarlp more abundantly than do normal membranes which have a low level of Secl2p . Independently, Oka et al . (1991) have shown that Sarlp isolated from transformed yeast or Escherichia coli suppresses temperature sensitive transport in the ER-Golgi transport reaction reconstituted with sec12 mutant membranes . Although all these results point to an interaction between Sarlp and Secl2p, the contact may not be direct or stable, and additional factors that may not be rate-limiting could mediate the interaction .
66 8 Figure 7 Secl2p-dependent membrane binding of Sarlp . Control microsomes (20 jig) (Microsomes G ; YPH500(pCGS109)) or Secl2p-rich membranes (Microsomes S ; YPH500(pCEY5)) were treated with trypsin (Trpsin + ; 200 jig/nil, 30 min, 4°C) . After inactivation of the protease, microsomes were mixed with either reaction buffer (Sarlp -) , 50 1~g of a Sarlp-rich cytosol (Sarlp C; YPH500(pANY2-18)) or 25 pl of partially purified Sarlp obtained after gel filtration of this same cytosol (Sarlp P) . In the latter case, BSA (1 mg/ml) was included to avoid Sarlp proteolysis . Sarlp-containing fractions were also incubated in the absence of membranes (Microsomes -) . After a 5-min incubation on ice, the soluble fraction (MSS) and membrane fraction (MSP) were separated by a 25,000 g centrifugation and their content analyzed by SDS-PAGE and immunoblotting with anti-Sarlp or anti-Secl2p antibodies .
Apart from SARI, genetic analysis had identified three other genes, SEC4, YP77, and ARFI, that encode small GTPbinding proteins required for protein transport at different steps along the secretory pathway (Salminen and Novick, 1987 ; Segev et al ., 1988; Stearns et al ., 1990) . In the case of Sec4p, localization of the protein as well as mutational analysis suggest that it is required for proper targeting and fusion of secretory vesicles to the plasma membrane (Goud et al ., 1988 ; Walworth et al., 1989) . Biochemical studies have shown that ER-to-Golgi transport and cis-to-medial Golgi transport is inhibited by GTPyS (Malengon et al., 1987 ; Baker et al ., 1988; Ruohola et al ., 1988 ; Beckers and Balch, 1989) and by synthetic peptides corresponding to the effector domain of members of the rab family of mammalian Sec4p/ Yptlp-related proteins (Plutner et al., 1990; Zaharoui et al ., 1989) . In mammalian cells, GTPyS inhibition results in the accumulation of intra-Golgi non-clathrin-coated-vesicles docked to their acceptor compartment (Melangon et al ., 1987 ; Orci et al ., 1989 ; Malhotra et al ., 1989) . In yeast, Yptlp is required for efficient in vitro ER to Golgi transport (Baker et al ., 1990; Bacon et al ., 1989) and its immobilization by Yptlp antibody Fab fragments results in the accumulation of transport vesicles en route to the Golgi (Rexach and Schekman, 1991) . Bourne (1988) has proposed a unifying model which suggests that each GTP-binding protein is required at a specific step to ensure an efficient targeting of vesicular carriers to their acceptor compartment . It appears that GTPyS also inhibits vesicle budding or release from the trans-Golgi network (Tooze et al ., 1990) and from the ER (Rexach and Schekman, 1991 ; Wuestehube, L., and R. Schekman, manuscript in preparation) . We have shown that Sarlp is required for vesicle assembly during ERGolgi transport and is thus the likely target of GTPyS inhibition in this process. A model forthe function of Sarlp in vesicle formation is proposed in Fig . 8 . Together with the involvement of Yptlp in ER-Golgi transport (Segev et al ., 1988 ; Baker et al ., 1990; Rexach and Schekman, 1991) , our results suggest that Sarlp and Yptlp may function in successive steps using GTP binding and hydrolysis to facilitate protein transport from the ER.
Structural differences between Sarlp and Yptlp support the view that they act at different stages during a single round of vesicular traffic . Whereas Yptlp is closely related to the mammalian oncogene ras (Gallwitz et al., 1982) , the Sarlp nucleotide binding site (G-1 and G-3 regions ; Bourne et al., 1991) is more closely related to the family of ADP ribosylation factors (ARF ; Kahn, 1990; Nakano and Muramatsu, 1989; Bourne et al., 1991) . ARF is associated with intraGolgi transport vesicles in mammalian cells (Serafini et al., 1990) and its yeast homologue, Arflp, is required for protein transport and also is localized to the Golgi apparatus (Sewell and Kahn, 1988 ; Stearns et al ., 1990) . ARF could play a role similar to that of Sarlp but at a later stage in secretion . Zahraoui et al ., 1989 ; Chavrier et al ., 1990) have at least one cysteine that is located near the COOH terminus of the protein . By analogy with the mammalian ras oncogene (Hancock et al ., 1989) , this residue is thought to be modified by a lipid, possibly a farnesyl analogue, which mediates membrane attachment (Molenaar et al ., 1988; Walworth et al., 1990 ) . Sarlp does not have a carboxyterminal cysteine nor any site of putative lipid modification that could explain its strong affinity for membranes . In this study, we have established an in vitro assay that measures the binding of Sarlp to ER membranes . Results presented in Fig. 7 show that Sarlp membrane attachment is stimulated by elevated levels of Secl2p. Thus, Sarlp may become membrane bound through the intervention of Secl2p .
Secl2p could act as a membrane anchor for Sarlp or alter the conformation of Sarlp so as to expose a hydrophobic surface enabling direct contact with the lipid bilayer. In both cases, Secl2p-specific membrane attachment of Sarlp could result in the regulated formation of an ER-Golgi transport vesicle at specific sites on the ER membrane . Studies with purified forms of both proteins will distinguish these possibilities .
